BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Watanabe R, Hosgur E, Zhang H, Wen Z, Berry G, Goronzy JJ, Weyand CM. Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis. Joint Bone Spine 2017;84:421-6. [PMID: 27663755 DOI: 10.1016/j.jbspin.2016.07.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Watanabe R, Berry GJ, Tian L, Goronzy JJ, Weyand CM. Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis. Circulation 2018;137:1934-48. [PMID: 29254929 DOI: 10.1161/CIRCULATIONAHA.117.030423] [Cited by in Crossref: 73] [Cited by in F6Publishing: 32] [Article Influence: 14.6] [Reference Citation Analysis]
2 Joyce Liao Y. Anti-Interleukin-6 Antibody as Treatment for Giant Cell Arteritis. J Neuroophthalmol 2018;38:558-60. [PMID: 30199508 DOI: 10.1097/WNO.0000000000000712] [Reference Citation Analysis]
3 Weyand CM, Watanabe R, Zhang H, Akiyama M, Berry GJ, Goronzy JJ. Cytokines, growth factors and proteases in medium and large vessel vasculitis. Clin Immunol 2019;206:33-41. [PMID: 30772599 DOI: 10.1016/j.clim.2019.02.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
4 Pradeep S, Smith JH. Giant Cell Arteritis: Practical Pearls and Updates. Curr Pain Headache Rep 2018;22:2. [PMID: 29344777 DOI: 10.1007/s11916-018-0655-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
5 Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schulze-Koops H, Schett G, Spiera R, Unizony SH, Collinson N. Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab. Arthritis Rheumatol 2019;71:1329-38. [PMID: 30835950 DOI: 10.1002/art.40876] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 11.0] [Reference Citation Analysis]
6 Watanabe R, Hashimoto M. Aging-Related Vascular Inflammation: Giant Cell Arteritis and Neurological Disorders. Front Aging Neurosci 2022;14:843305. [DOI: 10.3389/fnagi.2022.843305] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Weyand CM, Berry GJ, Goronzy JJ. The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease. J Leukoc Biol 2018;103:565-75. [PMID: 28848042 DOI: 10.1189/jlb.3MA0717-283] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
8 Croci S, Bonacini M, Muratore F, Caruso A, Fontana A, Boiardi L, Soriano A, Cavazza A, Cimino L, Belloni L, Perry O, Fridkin M, Parmeggiani M, Blank M, Shoenfeld Y, Salvarani C. The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis. J Autoimmun 2019;98:113-21. [PMID: 30638709 DOI: 10.1016/j.jaut.2019.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Watanabe R, Zhang H, Berry G, Goronzy JJ, Weyand CM. Immune checkpoint dysfunction in large and medium vessel vasculitis. Am J Physiol Heart Circ Physiol 2017;312:H1052-9. [PMID: 28314758 DOI: 10.1152/ajpheart.00024.2017] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 9.6] [Reference Citation Analysis]
10 Rynio P, Kazimierczak A, Gutowski P, Cnotliwy M. An unusual case of aortic rupture after deployment of a bare stent in the treatment of aortic dissection in a patient with giant-cell arteritis. Wideochir Inne Tech Maloinwazyjne 2017;12:194-8. [PMID: 28694908 DOI: 10.5114/wiitm.2017.67677] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Watanabe R, Berry GJ, Liang DH, Goronzy JJ, Weyand CM. Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis-Similarities and Differences. Curr Rheumatol Rep 2020;22:68. [PMID: 32845392 DOI: 10.1007/s11926-020-00948-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
12 Kalashnikova LA, Legenko MS, Shabalina AA, Dobrynina LA, Shamtieva KV, Kostyreva MV, Dreval MV, Lesnykh TA. [Primary vasculitis of internal carotid and vertebral arteries: a role of cytokines, transforming growth factor beta 1 and basic fibroblast growth factor]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:14-21. [PMID: 34460152 DOI: 10.17116/jnevro202112107114] [Reference Citation Analysis]
13 Weyand CM, Shen Y, Goronzy JJ. Redox-sensitive signaling in inflammatory T cells and in autoimmune disease. Free Radic Biol Med 2018;125:36-43. [PMID: 29524605 DOI: 10.1016/j.freeradbiomed.2018.03.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
14 Ren YL, Li TT, Cui W, Zhao LM, Gao N, Liao H, Zhang JH, Zhu JM, Qiao ZY, Guo SC, Pan LL. CD8+ T lymphocyte is a main source of interferon-gamma production in Takayasu's arteritis. Sci Rep 2021;11:17111. [PMID: 34429489 DOI: 10.1038/s41598-021-96632-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Watanabe R. CD4+ T Cells as Key Players in the Immunopathology of Takayasu Arteritis: Comment on the Article by. Arthritis Rheumatol 2020;72:696-7. [PMID: 31876121 DOI: 10.1002/art.41198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Maleszewski JJ, Younge BR, Fritzlen JT, Hunder GG, Goronzy JJ, Warrington KJ, Weyand CM. Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients. Mod Pathol 2017;30:788-96. [PMID: 28256573 DOI: 10.1038/modpathol.2017.10] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 15.6] [Reference Citation Analysis]
17 Bursi R, Cafaro G, Perricone C, Riccucci I, Calvacchi S, Gerli R, Bartoloni E. Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future. Front Pharmacol 2021;12:635663. [PMID: 33854436 DOI: 10.3389/fphar.2021.635663] [Reference Citation Analysis]
18 Li HY, Xu JN, Shuai ZW. Cellular signaling pathways of T cells in giant cell arteritis. J Geriatr Cardiol 2021;18:768-78. [PMID: 34659383 DOI: 10.11909/j.issn.1671-5411.2021.09.008] [Reference Citation Analysis]
19 Akiyama M, Ohtsuki S, Berry GJ, Liang DH, Goronzy JJ, Weyand CM. Innate and Adaptive Immunity in Giant Cell Arteritis. Front Immunol 2020;11:621098. [PMID: 33717054 DOI: 10.3389/fimmu.2020.621098] [Reference Citation Analysis]
20 Schwartz DM, Burma AM, Kitakule MM, Luo Y, Mehta NN. T Cells in Autoimmunity-Associated Cardiovascular Diseases. Front Immunol 2020;11:588776. [PMID: 33117403 DOI: 10.3389/fimmu.2020.588776] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Singh JA, Cleveland JD. The association of gout with incident giant cell arteritis in older adults. Joint Bone Spine 2019;86:219-24. [PMID: 29885976 DOI: 10.1016/j.jbspin.2018.05.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Watanabe R, Hashimoto M. Perspectives of JAK Inhibitors for Large Vessel Vasculitis. Front Immunol 2022;13:881705. [PMID: 35432355 DOI: 10.3389/fimmu.2022.881705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
23 Suh JH, Joo HS, Hong EB, Lee HJ, Lee JM. Therapeutic Application of Exosomes in Inflammatory Diseases. Int J Mol Sci 2021;22:1144. [PMID: 33498928 DOI: 10.3390/ijms22031144] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
24 Watanabe R, Berry GJ, Liang DH, Goronzy JJ, Weyand CM. Cellular Signaling Pathways in Medium and Large Vessel Vasculitis. Front Immunol 2020;11:587089. [PMID: 33072134 DOI: 10.3389/fimmu.2020.587089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
25 Watanabe R, Hashimoto M. Vasculitogenic T Cells in Large Vessel Vasculitis. Front Immunol 2022;13:923582. [DOI: 10.3389/fimmu.2022.923582] [Reference Citation Analysis]
26 Deshayes S, de Boysson H, Dumont A, Vivien D, Manrique A, Aouba A. An overview of the perspectives on experimental models and new therapeutic targets in giant cell arteritis. Autoimmunity Reviews 2020;19:102636. [DOI: 10.1016/j.autrev.2020.102636] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Lacy A, Nelson R, Koyfman A, Long B. High risk and low prevalence diseases: Giant cell arteritis. The American Journal of Emergency Medicine 2022;58:135-40. [DOI: 10.1016/j.ajem.2022.05.042] [Reference Citation Analysis]
28 Watanabe R, Hashimoto M. Pathogenic role of monocytes/macrophages in large vessel vasculitis. Front Immunol 2022;13:859502. [DOI: 10.3389/fimmu.2022.859502] [Reference Citation Analysis]